PTK7-targeting antibody-drug conjugate (AbTis/Y-Biologics)

N/A

Report date: 2025/06/11 10:21:23

Base Information

Drug NamePTK7-targeting antibody-drug conjugate (AbTis/Y-Biologics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionProtein-tyrosine kinase 7 modulators
TargetsProtein-tyrosine kinase 7
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbTis Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbTis Co LtdY-biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A